Brief: Mei Pharma Board Of Directors Rejects Unsolicited Proposal
01/06/2023 13:39
June 1 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA BOARD OF DIRECTORS REJECTS UNSOLICITED PROPOSAL
* MEI PHARMA INC - REJECTED UNSOLICITED AND NON-BINDING
PROPOSAL
RECEIVED ON MAY 23, FROM GROUP REPRESENTED BY ANSON ADVISORS
INC.& CABLE CAR CAPITAL
* MEI PHARMA INC - BOARD CONCLUDED THAT UNSOLICITED PROPOSAL
IS
"NOT SUPERIOR " TO PROPOSED TRANSACTION WITH INFINITY
PHARMACEUTICALS
Source text for Eikon: ID:nBwfPl0Sa
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations